Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02926430 · ClinicalTrials.gov registry record · Phase 1

A Study to Evaluate the Safety, Tolerability and Immunogenicity of Two Vaccinations of Ad26.RSV.preF One Year Apart in Adults Aged 60 Years and Older in Stable Health

A Phase 1 study of Healthy, sponsored by Janssen Vaccines & Prevention B.V..

Completed
Registry status
Phase 1
Development phase
73
Enrollment target
1
Study location

NCT02926430: Completed Phase 1 study of Healthy, sponsored by Janssen Vaccines & Prevention B.V..

NCT02926430 is a Phase 1 study of Healthy that has completed, run by Janssen Vaccines & Prevention B.V.. The registered enrollment target is 73 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02926430, a Phase 1 study of Healthy, has completed, sponsored by Janssen Vaccines & Prevention B.V..

COMPLETED
Registry status
Phase 1
Development phase
73 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess the safety and tolerability of 2 single doses of either 5\*10\^10 viral particles (vp) or 1\*10\^11 vp of Ad26.RSV.preF, administered intramuscularly to elderly adults given approximately 12 months apart.

Conditions Studied

Healthy

Interventions

  • DRUG Placebo
  • BIOLOGICAL Ad26.RSV.preF 5*10^10 vp
  • BIOLOGICAL Ad26.RSV.preF 1*10^11 vp

Study Locations (1)

Florida

  • - Miami

Trial Details

FieldValue
Enrollment Target 73 participants
Start Date 2016-11-08
Est. Completion 2019-01-29
Phase Phase 1

Sponsor

Janssen Vaccines & Prevention B.V.

34 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02926430

The ClinicalTrials.gov registry entry for NCT02926430 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (89% lower). The listed sponsor is Janssen Vaccines & Prevention B.V., which has 34 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT02926430 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT02926430 about?

NCT02926430 is a clinical study titled "A Study to Evaluate the Safety, Tolerability and Immunogenicity of Two Vaccinations of Ad26.RSV.preF One Year Apart in Adults Aged 60 Years and Older in Stable Health". The purpose of this study is to assess the safety and tolerability of 2 single doses of either 5\*10\^10 viral particles (vp) or 1\*10\^11 vp of Ad26.RSV.preF, administered intramuscularly to elderly adults given approximately 12 months apart.

What is the current status of trial NCT02926430?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 73 participants. The study started on 2016-11-08. Estimated completion is 2019-01-29.

What conditions does trial NCT02926430 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT02926430?

The interventions under investigation include: Placebo (DRUG), Ad26.RSV.preF 5*10^10 vp (BIOLOGICAL), Ad26.RSV.preF 1*10^11 vp (BIOLOGICAL).

Who is sponsoring clinical trial NCT02926430?

This trial is sponsored by Janssen Vaccines & Prevention B.V., which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02926430 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.